Notably, DCB-treated patients showed a trend toward fewer severe bleeding events at 3 years due to the ability to shorten the duration of DAPT and the absence of permanent implants.
← all excerpts
Clinical application and expansion of paclitaxel-coated balloons in coronary atherosclerotic disease.
1
—
—